• Product nameAnti-NCOA4 antibody
    See all NCOA4 primary antibodies
  • Description
    Mouse monoclonal to NCOA4
  • Tested applicationsSuitable for: ICC/IF, WBmore details
  • Species reactivity
    Reacts with: Human
  • Immunogen

    Recombinant full length protein, corresponding to amino acids 1-576 of Human NCOA4



Our Abpromise guarantee covers the use of ab56356 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
  • Application notesWB: Use at a concentration of 1-5 µg/ml.
    IF/ICC: Use at a concentration of 10 µg/ml.

    This antibody has only been tested in WB against the recombinant fragment used as immunogen. We have no data on the detection of endogenous protein.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionEnhances the androgen receptor transcriptional activity in prostate cancer cells. Ligand-independent coactivator of the peroxisome proliferator-activated receptor (PPAR) gamma.
    • Tissue specificityWidely expressed. Also detected in adipose tissues and in different cell lines. Isoform Beta is only expressed in testis.
    • Involvement in diseaseDefects in NCOA4 are a cause of thyroid papillary carcinoma (TPC) [MIM:188550]. TPC is a common tumor of the thyroid that typically arises as an irregular, solid or cystic mass from otherwise normal thyroid tissue. Papillary carcinomas are malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. Note=A chromosomal aberration involving NCOA4 is found in thyroid papillary carcinomas. Inversion inv(10)(q11.2;q11.2) generates the RET/NCOA4 (PTC3) oncogene that has been found in sporadic and radiation-associated post-Chernobyl thyroid papillary carcinomas.
    • Information by UniProt
    • Database links
    • Alternative names
      • 70 kDa androgen receptor activator antibody
      • 70 kDa androgen receptor coactivator antibody
      • 70 kDa AR activator antibody
      • 70 kDa AR-activator antibody
      • Androgen receptor coactivator 70 kD antibody
      • Androgen receptor coactivator 70 kDa protein antibody
      • Androgen receptor-associated protein of 70 kDa antibody
      • ARA 70 antibody
      • ARA70 antibody
      • DKFZp762E1112 antibody
      • ELE 1 antibody
      • ELE1 antibody
      • ELE1/ret TK antibody
      • NCOA 4 antibody
      • NCoA-4 antibody
      • NCOA4 antibody
      • NCOA4_HUMAN antibody
      • Nuclear receptor coactivator 4 antibody
      • Papillary thyroid carcinoma 3 antibody
      • PTC 3 antibody
      • PTC3 antibody
      • RET activating gene ELE1 antibody
      • Ret activating protein ELE1 antibody
      • Ret-activating protein ELE1 antibody
      • RFG antibody
      see all

    Anti-NCOA4 antibody images

    • NCOA4 antibody (ab56356) used in immunofluorescence at 10ug/ml on HeLa cells.
    • Western blot against tagged recombinant protein immunogen using ab56356 NCOA4 antibody at 1ug/ml. Predicted band size of immunogen is 89 kDa

    References for Anti-NCOA4 antibody (ab56356)

    ab56356 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab56356.
    Please use the links above to contact us or submit feedback about this product.